Biomendex
Develops synthetic bone graft substitutes for surgeons and veterinary clinicians
Highlights
- New on EvolcAdded 2026-10-30
About Biomendex
Biomendex develops and manufactures Adaptos® synthetic bone graft substitutes for tissue regeneration. The products are designed for use in bone procedures, including spine, orthopedic, and oral and maxillofacial surgery; Adaptos®Vet is commercially available for veterinary surgery.
The company sells medical devices and its veterinary product line through distributors and an online store. It also collaborates with clinical and research partners on product development and clinical studies.
Founded in 2018, Biomendex is based in Tampere, Finland, where its laboratory, clean-room, development, and production operations are located. Its team has 11 professionals.
Product: Adaptos® synthetic bone graft substitutes for human and veterinary procedures.
Jobs at Biomendex
Leadership
- Kaarlo Paakinaho · FounderSource: company website
- Mikko Manninen · FounderSource: company website
More biotech & pharma companies
BioNavis
Surface plasmon resonance and QCMD instruments for labs measuring molecular interactions and nanolayersNew on EvolcBlueprint Genetics
Genetic testing services and diagnostic test panels for healthcare providers, offered through an online ordering portalNew on EvolcBramble Cay
Field research, scientific tools and private projects involving living systems and ecosystemsYoung companyNew on EvolcDelSiTech
Silica-based long-acting injectable drug delivery platform for pharma and biopharma partners and in-house pipelineNew on EvolcDesentum
Develops investigational allergen immunotherapies for people with pollen, food and animal allergiesNew on EvolcEstiMates
Statistical, data management and bioinformatics services for clinical trials and life science research sponsorsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cookiebot
- Google Analytics 4
- Google reCAPTCHA
- WordPress
- jQuery